These upregulated pathways and the induction of genes in the insulin receptor signaling pathway, heat shock proteins and cell cycle regulators all support the idea that INMEST treatment upregulates disease tolerance pathways normally induced during infections, and possibly improperly suppressed in ME patients (Fig. 6A–C). This evidence concerns the gene INSR and infection.